Instituto de Investigación Sanitaria La Fe-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2024

  1. AntimiR treatment corrects myotonic dystrophy primary cell defects across several CTG repeat expansions with a dual mechanism of action

    Science advances, Vol. 10, Núm. 41, pp. eadn6525